Dr. Robbins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2610 Lake Cook Rd
Ste 160
Riverwoods, IL 60015Phone+1 847-374-9399Fax+1 847-374-9393
Education & Training
- University of Illinois College of Medicine at ChicagoResidency, Neurology, 1981 - 1985
- University of Illinois College of MedicineClass of 1981
- University of MichiganB.S., Zoology and Psychology, 1976
Certifications & Licensure
- AZ State Medical License 1985 - Present
- IL State Medical License 1982 - 2026
Awards, Honors, & Recognition
- Nominated for AAN award given to a neurologist who serves indigent patients 2019
- Added Qualification in Headache Medicine (a certificate in advanced headache practice) National Headache Foundation, 2016
- Clinical Excellence Award 2015
- Join now to see all
Clinical Trials
- A Study of Galcanezumab in Participants With Chronic Cluster Headache Start of enrollment: 2015 Jun 18
Publications & Presentations
PubMed
- 10 citationsErenumab Side Effects.Lawrence Robbins
Headache. 2019-07-01 - 72 citationsIntranasal Lidocaine for Cluster HeadacheLawrence Robbins
Headache. 1995-02-01 - 134 citationsPrecipitating Factors in Migraine: A Retrospective Review of 494 PatientsLawrence D. Robbins
Headache. 1994-04-01
Journal Articles
- Effects of OnabotulinumtoxinA Treatment for Chronic Migraine on Common Comorbidities including Depression and AnxietyBlumenfeld A, Tepper S, Robbins L, Manack Adams A, Buse D, Orejudos A, Silberstein S, Journal of Neurology, Neurology, and Psychiatry, 1/1/2019
- CGRP Antagonists: Physiologic Effects and Serious Side Effects (Letter)Robbins L, Headache, 1/1/2018
- At Stake: The Possible Long-term Side effects of CGRP AntagonistsRobbins L, PPM Journal, 1/1/2018
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Effect of OnabotulinumtoxinA Prevention on Comorbidities of Depression and Anxiety in Chronic Migraine: Analysis in Headache Day Frequency Responders vs Headache Day F...Blumenfeld A, Tepper S, Robbins L, Orejudos A, Manack Adams A, Buse D, Silberstein S, Multiple Presentations, Multiple Locations, 2018, 2019, 1/1/2019
- Effects of OnabotulinumtoxinA Treatment on Chronic Migraine Comorbidities of Depression and Anxiety: Psychiatric Comorbidities Responder Analysis.Blumenfeld A, Tepper S, Robbins L, Manack Adams A, Buse D, Silberstein S, American Academy of Neurology, Los Angeles, CA, 1/21/2018
- The Effects of OnabotulinumtoxinA Treatment on the Chronic Migraine Comorbidities of Sleep and Fatigue.Blumenfeld A, Tepper S, Robbins L, Manack Adams A, Silberstein S, Multiple Presentations, Multiple Locations, 2017, 2018, 1/1/2018
- Join now to see all
Lectures
- Choosing Headache Meds: Deconstructing the Art of Headache Medicine(with Clinical Pearls)1/1/2018
- Personality Disorder and The Bipolar Spectrum in Pain Patients1/1/2018
- Refractory Headache1/1/2018
- Join now to see all
Other
- Early Data on the first CGRP inhibitor for migraine (Aimovig)Robbins L, Practical Pain Management (Online Only)
1/1/2018 - CGRP Antagonists: Long-term effectsRobbins L, Southern Pain Society Newslette
1/1/2018 - Medication Overuse Headache: A PerspectiveRobbins L, Southern Pain Society Newsletter
1/1/2018 - Join now to see all
Press Mentions
- Skin Patch Resolves Migraine Pain More Quickly with Fewer Side EffectsNovember 2nd, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: